Seminar “Mathematical modeling helps to better understand the mechanisms B-cell lymphomas acquired resistance to BTK inhibitor treatment”

Seminar “Mathematical modeling helps to better understand the mechanisms B-cell lymphomas acquired resistance to BTK inhibitor treatment”

The event passed
13 Jan
Location
Online
Contact person
Mozokhina Anastasiia
About the event

13 January at 16:30 MSK

Chronic activation of B-cell receptor (BCR) signaling via Bruton tyrosine kinase (BTK) is largely considered to be one of the primary mechanisms driving disease progression in B-cell lymphomas, particularly, ABC DLBCL. Although the BTK-targeting agent ibrutinib has shown promising clinical responses, the presence of primary or acquired resistance is common that leads to disease progression. Resistance to ibrutinib therapy can be mediated through genetic mutations, up-regulation of alternative survival pathways, or other unknown factors that are not targeted by ibrutinib therapy. In this work we did mathematical modeling of signaling pathways and transcriptional perturbations in B-cell lymphoma cells under BTK inhibitor treatment which might leads to ibrutinib resistant phenotype.

Online

Speaker

Yuri Kosinsky, senior principal scientist, M&S Decisions LLC.

Related eventsAll events
2022
30 May
Seminar “Unmanned Aerial Vehicles (UAVs) powers the future of 5G/6G networks”
2022
24 May
Seminar “Boundary value problems for semilinear Schrodinger equations with Hardy-type potentials”
2022
24 May
Scientific seminar “The second boundary value problem for differential-difference equations with variable coefficients on an interval of integer length”
2022
20 May
Scientific seminar "Modern problems of the geoenvironment"